1,25-Dihydroxyvitamin D3 and 1,24-dihydroxyvitamin D3 suppress in vitro antibody response to T cell-dependent antigen. 1985

K Komoriya, and I Nagata, and M Tsuchimoto, and K Kunisawa, and T Takeshita, and T Naruchi

1,25-Dihydroxyvitamin D3 and 1,24-dihydroxyvitamin D3 suppressed an antibody response to sheep red blood cells (SRBC, T cell-dependent antigen) by murine splenocytes, in concentrations ranging from 10(-10)-10(-7)M. These suppressive effects were markedly abrogated when T cell-depleted lymphocytes were cultured in the presence of a supernatant of concanavalin A-stimulated spleen cells. On the contrary, neither of them suppressed antibody response to trinitrophenyl-lipopolysaccharide (T cell-independent antigen). These results suggest that the suppressive effect of active vitamin D3 on anti-SRBC response was mediated by the inhibition of T cells.

UI MeSH Term Description Entries
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002117 Calcitriol The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption. 1 alpha,25-Dihydroxycholecalciferol,1 alpha,25-Dihydroxyvitamin D3,1, 25-(OH)2D3,1,25(OH)2D3,1,25-Dihydroxycholecalciferol,1,25-Dihydroxyvitamin D3,1 alpha, 25-dihydroxy-20-epi-Vitamin D3,1,25(OH)2-20epi-D3,1,25-dihydroxy-20-epi-Vitamin D3,20-epi-1alpha,25-dihydroxycholecaliferol,Bocatriol,Calcijex,Calcitriol KyraMed,Calcitriol-Nefro,Decostriol,MC-1288,MC1288,Osteotriol,Renatriol,Rocaltrol,Silkis,Sitriol,Soltriol,Tirocal,1 alpha,25 Dihydroxyvitamin D3,1,25 Dihydroxycholecalciferol,1,25 Dihydroxyvitamin D3,1,25 dihydroxy 20 epi Vitamin D3,Calcitriol Nefro,D3, 1 alpha,25-Dihydroxyvitamin,D3, 1,25-Dihydroxyvitamin,D3, 1,25-dihydroxy-20-epi-Vitamin,KyraMed, Calcitriol,MC 1288
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003208 Concanavalin A A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.
D004100 Dihydroxycholecalciferols Cholecalciferols substituted with two hydroxy groups in any position. Dihydroxyvitamins D
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen

Related Publications

K Komoriya, and I Nagata, and M Tsuchimoto, and K Kunisawa, and T Takeshita, and T Naruchi
October 1984, Journal of immunology (Baltimore, Md. : 1950),
K Komoriya, and I Nagata, and M Tsuchimoto, and K Kunisawa, and T Takeshita, and T Naruchi
October 2008, Oncology reports,
K Komoriya, and I Nagata, and M Tsuchimoto, and K Kunisawa, and T Takeshita, and T Naruchi
September 1990, Clinical and experimental dermatology,
K Komoriya, and I Nagata, and M Tsuchimoto, and K Kunisawa, and T Takeshita, and T Naruchi
March 2013, The Journal of clinical endocrinology and metabolism,
K Komoriya, and I Nagata, and M Tsuchimoto, and K Kunisawa, and T Takeshita, and T Naruchi
January 1998, Anticancer research,
K Komoriya, and I Nagata, and M Tsuchimoto, and K Kunisawa, and T Takeshita, and T Naruchi
January 2014, PloS one,
K Komoriya, and I Nagata, and M Tsuchimoto, and K Kunisawa, and T Takeshita, and T Naruchi
May 1985, Journal of immunology (Baltimore, Md. : 1950),
K Komoriya, and I Nagata, and M Tsuchimoto, and K Kunisawa, and T Takeshita, and T Naruchi
December 1989, Proceedings of the National Academy of Sciences of the United States of America,
K Komoriya, and I Nagata, and M Tsuchimoto, and K Kunisawa, and T Takeshita, and T Naruchi
May 1994, The Journal of biological chemistry,
K Komoriya, and I Nagata, and M Tsuchimoto, and K Kunisawa, and T Takeshita, and T Naruchi
June 1997, Transplantation proceedings,
Copied contents to your clipboard!